Corporate Governance

Investor Resources
Contact Us
Investor ResourcesCorporate Governance

Board Members on Committees

Chair      Member
Director Audit Compensation Governance
Jennifer M. Chao, BA
Guillermo Torre-Amione, MD, PhD
Peter Pekos, BSc, MSc
Teri Loxam, MBA
Colin G. Stott, BSc (Hons)
Michael J. Willner, Esq.

Governance Documents

  • Audit Committee Charter
  • Board of Directors Mandate
  • Code of Business Conduct and Ethics
  • Corporate Governance and Compensation Committee Mandate
  • Insider Trading Policy
  • Whistleblower Policy
  • Confidentiality and Disclosure Policy
  • Nasdaq Statement of Governance Differences

Corporate Documents

  • Articles of Incorporation
  • Articles of Amendment (August 29, 2018)
  • Articles of Amendment (February 13, 2017)
  • By-Law No. 1.
  • Majority Voting Policy

Board Diversity Matrix

Country of Principal Executive Offices: Canada
Foreign Private Issuer: Yes
Disclosure Prohibited Under Home Country Law: No
Total Number of Directors: 8

Part I: Directors Gender Identity

Female 2
Male 6
Non-Binary 0
Did Not Disclose Gender 0

Part II: Demographic Background

Underrepresented Individual in Home Country Jurisdiction 1
LGBTQ+ 0
Did Not Disclose Demographic Background 4

Country of Principal Executive Offices: Canada
Foreign Private Issuer: Yes
Disclosure Prohibited Under Home Country Law: No
Total Number of Directors: 8

Part I: Directors Gender Identity

Female 2
Male 6
Non-Binary 0
Did Not Disclose Gender 0

Part II: Demographic Background

Underrepresented Individual in Home Country Jurisdiction 1
LGBTQ+ 0
Did Not Disclose Demographic Background 5

2024 Cardiol Therapeutics. All right reserved.